Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0XU3A
|
|||
| Drug Name |
PMID25656651-Compound-23c
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA DAR, Arvin SHOKAT, Kevan M
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C28H28F3N7O2
|
|||
| Canonical SMILES |
CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC=C(C=C3)NC(=O)NC4=CC=CC(=C4)C(F)(F)F)NC(=O)C5CCCC5
|
|||
| InChI |
1S/C28H28F3N7O2/c1-16(2)38-25-22(24(32-15-33-25)36-26(39)18-6-3-4-7-18)23(37-38)17-10-12-20(13-11-17)34-27(40)35-21-9-5-8-19(14-21)28(29,30)31/h5,8-16,18H,3-4,6-7H2,1-2H3,(H2,34,35,40)(H,32,33,36,39)
|
|||
| InChIKey |
HXLONDQXUGAZKS-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fusion protein Bcr-Abl (Bcr-Abl) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fusion protein Bcr-Abl (Bcr-Abl) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.